Concepedia

Julia Lull

JL

Statistics

Publications

4

Citations

2.4K

H-Index

4

Active since

2000

Affiliations

Johnson & Johnson (United States)(Current)

Julia Lull is an author at Johnson & Johnson (United States) specializing in rehabilitation, medicine, and psychopharmacology.

Top concepts

Publications per year

2000–2014

4

Publications

4

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia

Gahan Pandina, Jean‐Pierre Lindenmayer, Julia Lull et al. · Journal of Clinical Psychopharmacology · 2010 · 199 citations

, , +16

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

Srihari Gopal, David Hough, Haiyan Xu et al. · International Clinical Psychopharmacology · 2010 · 153 citations

, , +13

A longitudinal study of T1 hypointense lesions in relapsing MS

Jack H. Simon, Julia Lull, L. D. Jacobs et al. · Neurology · 2000 · 132 citations

1–4 of 4